Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Notice For The Meeting Of Board Of Directors / Closure Of Trading Window

 We inform that a meeting of the Board of Directors of the Company will be held on Monday, November 13, 2017 to consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2017. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from...
11-10-2017
Bigul

Certificate Under Regulation 40 (10) Of SEBI (LODR) Regulations, 2015

 The certificate as required under Regulation 40[10] of the SEBI [Listing Obligations and Disclosure Requirements], Regulations, 2017 for the half year - April 1, 2017 to September 30, 2017, issued by Hitesh Buch & Associates, Practicing Company Secretaries.
11-10-2017
Bigul

Compliance Under Regulation 40 (10) Of SEBI (LODR), 2015

 The certificate as required under Regulation 40[10] of the SEBI [Listing Obligations and Disclosure Requirements], Regulations, 2017 for the half year - April 1, 2017 to September 30, 2017, issued by Hitesh Buch & Associates, Practicing Company Secretaries.
11-10-2017
Bigul

Compliance Under Regulation 40 (10) Of SEBI (LODR), 2015

 The certificate as required under Regulation 40[10] of the SEBI [Listing Obligations and Disclosure Requirements], Regulations, 2017 for the half year - April 1, 2017 to September 30, 2017, issued by Hitesh Buch & Associates, Practicing Company Secretaries.
11-10-2017
Bigul

Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On September 30, 2017.

 Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Half Year ended on September 30, 2017.
07-10-2017
Bigul

Status Of Complaints As On September 30, 2017

 In compliance with the provisions of Regulation 13[3] of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, the status of Investor Complaints as on September 30, 2017 is as under: Sr. No. Particulars Status of Complaints 1. Complaints pending at the beginning of the quarter Nil 2. Complaints received during the quarter 3 3. Complaints disposed of during the quarter 3 4. Complaints remaining unresolved at the end of the quarter Nil
07-10-2017
Bigul

Shareholding for the Period Ended September 30, 2017

 Zydus Wellness Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here
06-10-2017
Bigul

Zydus gets USFDA nod to market anti-diuretic nasal spray

 Zydus Cadila has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray solution in the American market. The drug firm has received final approval...
04-10-2017
Bigul

Zydus gets USFDA nod for doxycycline tablets

 Zydus Cadila has received final approval from the US health regulator to market doxycycline tablets, used for the treatment of different types of bacterial infections such as acne and eye infection.
29-09-2017

Zydus Pharma recalls 44,800 bottles of antidepressant in US

 Cadila Healthcare's US arm, Zydus Pharmaceuticals USA Inc, is recalling 44,800 bottles of antidepressant Paroxetine tablets from the American market
21-09-2017
Next Page
Close

Let's Open Free Demat Account